Hematoma: Clinical Trials

3 trials for Hematoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3
Phase 22Terminated 2

Follow Hematoma: new trials by email Literature Review of Hematoma trials Research Report on Hematoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery
Tranexamic acid and Tocilizumab - Chronic Subdural Hematoma
Phase 2 / Phase 3TerminatedOslo University Hospital3822017-11-282021-10-13
Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma
Dexamethasone, Burr Hole Craniostomy - Chronic Subdural Hematoma
Phase 2 / Phase 3TerminatedUniversity of Virginia102014-03-012018-12-11
Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas
oral corticosteroids, placebo - Chronic Intracranial Subdural Hematoma
Phase 3TerminatedUniversity Hospital, Montpellier1622011-07-222026-06-02

Narrower conditions

Hematoma, Subdural, Chronic (3)  ·  Recurrence (1)

Broader conditions

Brain Diseases (3)  ·  Cardiovascular Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Cerebrovascular Disorders (3)  ·  Chronic Disease (3)  ·  Craniocerebral Trauma (3)  ·  Disease Attributes (3)  ·  Hematoma, Subdural (3)  ·  Hemorrhage (3)  ·  Intracranial Hemorrhage, Traumatic (3)  ·  Intracranial Hemorrhages (3)  ·  Nervous System Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)

Interventions

Adrenal Cortex Hormones (1)  ·  Dexamethasone (1)  ·  Prednisone (1)  ·  Tranexamic Acid (1)  ·  tocilizumab (1)

Sponsors

Oslo University Hospital (1)  ·  University Hospital, Montpellier (1)  ·  University of Virginia (1)

Countries

France (1)  ·  Norway (1)  ·  United States (1)

Top investigators

Jennifer De Jong (1)  ·  Lonjon Nicolas, MD,PhD (1)  ·  Milo Stanisic (1)

Results publications

PMID 33787345, PMID 42423601

NIH funding

2009 (1), 2017 (1)